Hart AA - Search Results

1

Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment.

Boogerd W, Hart AA, van der Sande JJ, Engelsman E. Boogerd W, et al. Among authors: hart aa. Cancer. 1991 Mar 15;67(6):1685-95. doi: 10.1002/1097-0142(19910315)67:6<1685::aid-cncr2820670635>3.0.co;2-m. Cancer. 1991. PMID: 2001559

2

Brain metastases in breast cancer; natural history, prognostic factors and outcome.

Boogerd W, Vos VW, Hart AA, Baris G. Boogerd W, et al. Among authors: hart aa. J Neurooncol. 1993 Feb;15(2):165-74. doi: 10.1007/BF01053937. J Neurooncol. 1993. PMID: 8509821

3

Treatment and outcome of brain metastasis as first site of distant metastasis from breast cancer.

Boogerd W, Hart AA, Tjahja IS. Boogerd W, et al. Among authors: hart aa. J Neurooncol. 1997 Nov;35(2):161-7. doi: 10.1023/a:1005818323996. J Neurooncol. 1997. PMID: 9266454

4

Outcome of patients with primary central nervous system lymphoma treated outside clinical trials.

Hart A, Baars JW, Kersten MJ, Brandsma D, van Tinteren H, de Jong D, Spiering M, Dewit L, Boogerd W. Hart A, et al. Neth J Med. 2014 May;72(4):218-23. Neth J Med. 2014. PMID: 24829178 Free article.

5

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence.

Kemperman H, Borger J, Hart A, Peterse H, Bartelink H, van Dongen J. Kemperman H, et al. Eur J Cancer. 1995;31A(5):690-8. doi: 10.1016/0959-8049(94)00526-b. Eur J Cancer. 1995. PMID: 7640040

6

Primary axillary radiotherapy as axillary treatment in breast-conserving therapy for patients with breast carcinoma and clinically negative axillary lymph nodes.

Hoebers FJ, Borger JH, Hart AA, Peterse JL, Th EJ, Lebesque JV. Hoebers FJ, et al. Among authors: hart aa. Cancer. 2000 Apr 1;88(7):1633-42. doi: 10.1002/(sici)1097-0142(20000401)88:7<1633::aid-cncr18>3.0.co;2-s. Cancer. 2000. PMID: 10738222

7

The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: a population-based study.

Bergman L, Kluck HM, van Leeuwen FE, Crommelin MA, Dekker G, Hart AA, Coebergh JW. Bergman L, et al. Among authors: hart aa. Eur J Cancer. 1992;28A(8-9):1475-80. doi: 10.1016/0959-8049(92)90547-f. Eur J Cancer. 1992. PMID: 1515270

8

Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer.

Bruning PF, Pit MJ, de Jong-Bakker M, van den Ende A, Hart A, van Enk A. Bruning PF, et al. Br J Cancer. 1990 Feb;61(2):308-10. doi: 10.1038/bjc.1990.58. Br J Cancer. 1990. PMID: 2310683 Free PMC article.

9

The prognostic significance of the axillary apex biopsy in clinically operable breast cancer.

van Tienhoven G, Borger JH, Passchier DH, Hart AA, Rutgers EJ, van Dongen JA, Bartelink H. van Tienhoven G, et al. Among authors: hart aa. Eur J Cancer. 1995 Nov;31A(12):1965-8. doi: 10.1016/0959-8049(95)00484-x. Eur J Cancer. 1995. PMID: 8562149

10

The development of a prognostic score for patients with parotid carcinoma.

Vander Poorten VL, Balm AJ, Hilgers FJ, Tan IB, Loftus-Coll BM, Keus RB, van Leeuwen FE, Hart AA. Vander Poorten VL, et al. Among authors: hart aa. Cancer. 1999 May 1;85(9):2057-67. Cancer. 1999. PMID: 10223248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters